GPCR — Structure Therapeutics Share News
0.000.00%
Last trade - 00:00US-listed Novo shares slip after company flags sharp 2026 sales drop
Structure expects pills to capture up to 50% of GLP-1 obesity market by 2030 (updated)
Structure expects pills to capture 25% to 50% of GLP-1 obesity market by 2030
What to Watch in the Day Ahead - Tuesday, January 13
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (updated)
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Brief: Structure Therapeutics Inc - Gasherbrum Entered Agreement With Genentech And Roche - SEC Filing
Structure Therapeutics doubles while other obesity drug developers decline
Factbox: Top pharma companies racing to launch first weight-loss pill
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Obesity pill maker Structure gains after Lilly's pill shows promising trial data
Brief: Structure Therapeutics Starts Phase 1 Study Of Oral Amylin Agonist ACCG‑2671
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. STOCKS ON THE MOVE-Five Below, Boeing, Instacart
Buzz Us Stocks On The Move: Tesla, Warner Bros Discovery, Netflix
NASDAQ RESUMED AT 10:22 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:17 AM
NASDAQ RESUMED AT 10:08 AM
Structure Therapeutics surges after weight-loss drug succeeds mid-stage trial